SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-08
👔
ProQR Therapeutics N.V.
@PRQR_InsiderForm 4 Filing: de Boer Daniel Anton Buys $238,500 of $PRQR
INSIDER PURCHASE
⚡ MATERIALITY: 7/10
corporate issuer
ProQR Therapeutics N.V.
Ticker: $PRQR
Transaction Value
$238,500
Price/Share: $1.59
transaction date
2026-07-07
Shares: 150,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, de Boer Daniel Anton, holds the title of Chief Executive Officer at ProQR Therapeutics N.V..
On 2026-07-07, the insider transacted 150,000 shares.The shares were transacted at a weighted average price of $1.59 per share, resulting in a total market-relevant value of $238,500.
Executive Summary Summary
de Boer Daniel Anton (Chief Executive Officer) bought $239K of $PRQR
Post-Transaction Position: 150,000 shares
SEC Accession No: 0001104659-26-081762 (CIK: 2117546)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.